NKGNW
NKGen Biotech, Inc. Warrants
NKGNW
NKGNW
Delisted
NKGNW was delisted on the 4th of March, 2025.
38 hedge funds and large institutions have $1.43M invested in NKGen Biotech, Inc. Warrants in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
38
Holding in Top 10
–
Calls
$15K
Puts
–
Top Buyers
| 1 | +$39.2K | |
| 2 | +$12.7K | |
| 3 | +$8.5K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.09K |
| 5 |
ETH
Exos TFP Holdings
New York
|
+$4.25K |
Top Sellers
| 1 | -$43K | |
| 2 | -$29K | |
| 3 | -$7K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$3.4K |
| 5 |
JPMorgan Chase & Co
New York
|
-$3K |